The burgeoning landscape of medication for obesity and type 2 metabolic disorder is currently witnessing considerable excitement surrounding both retatrutide and tirzepatide. While both represent novel dual GIP and https://theoiedn956970.theblogfairy.com/37819499/retatrutide-vs-tirzepatide-a-comparative-analysis